An examination of the relationship between non-depression-related costs and uninterrupted Tx

Formulary

Volumn 36, Issue 6, 2001, Pages 461-468

  Armstrong, E P ^a   Abarca, J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; COST OF ILLNESS; DEPRESSION; EMERGENCY WARD; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HOSPITAL PATIENT; HUMAN; MANAGED CARE; OUTPATIENT; PHYSICIAN;

EID: 0034965422     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. The national depressive and manic-depressive association consensus statement on the undertreatment of depression
2. Epidemiology and costs of depression: A hidden burden
3. Pharmacologic treatment of acute major depression and dysthymia
4. The underrecognition and undertreatment of depression: What is the breadth and depth of the problem?
5. Depression. Interventions and their effectiveness
6. A systematic review of newer pharmacotherapies for depression in adults: Evidence report summary
7. Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline
8. A framework for drug utilization evaluation in depression. Insights from outcomes research
9. Utilization patterns of antidepressant medications in a patient population served by a primary care medical group
10. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression
11. Use of claims data for research on treatment and outcomes of depression care
12. Selective contracting and patient outcomes: A case study of formulary restrictions for selective serotonin reuptake inhibitor antidepressants
13. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants
14. What does the treatment of depression really cost?
15. Patterns of antidepressant use and their relation to costs of care
16. Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: A multivariate analysis
17. Antidepressant pharmacotherapy: Economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organization
18. The role of SSRI antidepressants for treating depressed patients in the California Medicaid (Medi-Cal) program
19. Variance in treatment compliance and costs by antidepressant class: Analysis in an HMO setting
20. Predictors of a medical-offset effect among patients receiving antidepressant therapy
21. Tutorial on modeling ordered categorical response data
22. How to use multiple logistic regression in retrospective data-base analyses
23. A chronic disease score from automated pharmacy data
24. Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery